Show simple item record

dc.contributor.authorBeaten, J M
dc.contributor.authorMcclelland, R S
dc.contributor.authorOverbaugh, J
dc.contributor.authorEmery, S
dc.contributor.authorRichardson, B A
dc.contributor.authorLavreys, L
dc.contributor.authorMandaliya, K
dc.contributor.authorBankson, D D
dc.contributor.authorNdinya-Achola, JO
dc.contributor.authorBwayo, JJ
dc.contributor.authorKreiss, J K
dc.date.accessioned2013-05-30T11:42:21Z
dc.date.available2013-05-30T11:42:21Z
dc.date.issued2002
dc.identifier.citationBeaten Jm, Mcclelland Rs, Overbaugh J, Richardson Ba< Emery S, Lavreys L, Mandaliya K, Bankson Dd, Ndinya-achola Jo, Bwayo Jj, Kreiss Jk. Vitamin A Supplementation And Human Immunodeficiency Virus Type 1 Shedding In Women: Results Of A Randomised Clinical, O., Prof. Ndinya-achola J. , J Infect Dis 2002;185:1187-91, (2002)en
dc.identifier.uriHttp://profiles.uonbi.ac.ke/jndinya/publications/beaten-jm-mcclelland-rs-overbaugh-j-richardson-ba-emery-s-lavreys-l-mandaliya-k
dc.identifier.urihttp://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/27628
dc.description.abstract{ Observational studies have associated vitamin A deficiency with vaginal shedding of human immunodeficiency virus (HIV) type 1-infected cells and mother-to-child HIV-1 transmission. To assess the effect of vitamin A supplementation on vaginal shedding of HIV-1, a randomized, double-blind, placebo-controlled trial of 6 weeks of daily oral vitamin A (10,000 IU of retinyl palmitate) was conducted among 400 HIV-1-infected women in Mombasa, Kenya. At follow-up, there was no statistically significant difference in the prevalence of HIV-1 DNA (18% vs. 21%en
dc.language.isoenen
dc.publisherUniversity of Nairobien
dc.titleVitamin A Supplementation And Human Immunodeficiency Virus Type 1 Shedding In Women:en
dc.typeArticleen
local.publisherSchool of Medicineen


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record